EU approves Sanofi, Regeneron's Dupixent for adolescent eczema cases
The Dupixent product developed by French healthcare company Sanofi and its U.S. partner Regeneron has won regulatory approval in Europe for moderate-to-severe cases of eczema in adolescents, the companies said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news